309 related articles for article (PubMed ID: 18949548)
21. Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome.
Zhang R; Song Q; Liu H; Bai H; Zhang Y; Liu Q; Guan L; Fan P
Lipids Health Dis; 2017 Mar; 16(1):57. PubMed ID: 28320416
[TBL] [Abstract][Full Text] [Related]
22. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
[TBL] [Abstract][Full Text] [Related]
23. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
Eisaf M; Tselepis AD
Biochem Pharmacol; 2003 Dec; 66(11):2069-73. PubMed ID: 14609731
[TBL] [Abstract][Full Text] [Related]
24. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.
Kono N; Inoue T; Yoshida Y; Sato H; Matsusue T; Itabe H; Niki E; Aoki J; Arai H
J Biol Chem; 2008 Jan; 283(3):1628-1636. PubMed ID: 18024956
[TBL] [Abstract][Full Text] [Related]
25. Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits.
Arakawa H; Qian JY; Baatar D; Karasawa K; Asada Y; Sasaguri Y; Miller ER; Witztum JL; Ueno H
Circulation; 2005 Jun; 111(24):3302-9. PubMed ID: 15956136
[TBL] [Abstract][Full Text] [Related]
26. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
[TBL] [Abstract][Full Text] [Related]
27. Determination of phospholipase activity of PAF acetylhydrolase.
Stafforini DM; McIntyre TM
Free Radic Biol Med; 2013 Jun; 59():100-7. PubMed ID: 22659315
[TBL] [Abstract][Full Text] [Related]
28. Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.
Kom GD; Schwedhelm E; Maas R; Schneider L; Benndorf R; Böger RH
Br J Clin Pharmacol; 2007 Jun; 63(6):672-9. PubMed ID: 17214829
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults.
Detopoulou P; Nomikos T; Fragopoulou E; Panagiotakos DB; Pitsavos C; Stefanadis C; Antonopoulou S
Lipids Health Dis; 2009 Jun; 8():19. PubMed ID: 19500354
[TBL] [Abstract][Full Text] [Related]
30. Activity of platelet activating factor acetylhydrolase following phase I periodontal therapy.
Keles GC; Cetinkaya BO; Pamuk F; Balli U
West Indian Med J; 2013 Jan; 62(1):62-7. PubMed ID: 24171330
[TBL] [Abstract][Full Text] [Related]
31. The effect of lipoprotein-associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice.
Jiang Z; Fehrenbach ML; Ravaioli G; Kokalari B; Redai IG; Sheardown SA; Wilson S; Macphee C; Haczku A
Respir Res; 2012 Nov; 13(1):100. PubMed ID: 23140447
[TBL] [Abstract][Full Text] [Related]
32. Development of a seaweed derived platelet activating factor acetylhydrolase (PAF-AH) inhibitory hydrolysate, synthesis of inhibitory peptides and assessment of their toxicity using the Zebrafish larvae assay.
Fitzgerald C; Gallagher E; O'Connor P; Prieto J; Mora-Soler L; Grealy M; Hayes M
Peptides; 2013 Dec; 50():119-24. PubMed ID: 24140404
[TBL] [Abstract][Full Text] [Related]
33. Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid.
Seo HS; Kim JH; Nahm MH
Clin Vaccine Immunol; 2006 Apr; 13(4):452-8. PubMed ID: 16603612
[TBL] [Abstract][Full Text] [Related]
34. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
Tellis CC; Tselepis AD
Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
[TBL] [Abstract][Full Text] [Related]
36. Platelet activating-factor acetylhydrolase II: A member of phospholipase A2 family that hydrolyzes oxidized phospholipids.
Dong L; Li Y; Wu H
Chem Phys Lipids; 2021 Sep; 239():105103. PubMed ID: 34116047
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme.
Min JH; Wilder C; Aoki J; Arai H; Inoue K; Paul L; Gelb MH
Biochemistry; 2001 Apr; 40(15):4539-49. PubMed ID: 11294621
[TBL] [Abstract][Full Text] [Related]
38. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
Satoh K
Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
Fan P; Liu H; Wang Y; Zhang F; Bai H
Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
[TBL] [Abstract][Full Text] [Related]
40. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients.
Phumala Morales N; Cherlermchoung C; Fucharoen S; Chantharaksri U
Clin Chem Lab Med; 2007; 45(7):884-9. PubMed ID: 17617032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
